PC
IMCR icon

Pier Capital’s Immunocore IMCR Stock Holding History

Pier Capital’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-82,480
Closed -$2.57M – 137
2024
Q3 		$2.57M Buy
82,480
+1,174
+1% +$42.7K 0.36% 97
2024
Q2 		$2.76M Sell
81,306
-6,748
-8% -$344K 0.41% 95
2024
Q1 		$5.72M Buy
88,054
+1,852
+2% +$127K 0.79% 63
2023
Q4 		$5.89M Sell
86,202
-1,220
-1% -$63.4K 0.84% 63
2023
Q3 		$4.54M Buy
87,422
+19,135
+28% +$1.13M 0.73% 70
2023
Q2 		$4.09M Sell
68,287
-257
-0.4% -$14.7K 0.59% 83
2023
Q1 		$3.39M Sell
68,544
-189
-0.3% -$10.6K 0.51% 92
2022
Q4 		$3.92M Sell
68,733
-973
-1% -$54.8K 0.64% 75
2022
Q3 		$3.27M Sell
69,706
-53,688
-44% -$2.56M 0.56% 82
2022
Q2 		$4.6M Sell
123,394
-113,222
-48% -$3.68M 0.79% 68
2022
Q1 		$7.08M Sell
236,616
-1,160
-0.5% -$29.3K 0.9% 65
2021
Q4 		$8.14M Buy
237,776
+159,262
+203% +$5.77M 0.86% 67
2021
Q3 		$2.91M Buy
+78,514
New +$2.65M 0.3% 98

Other funds holding IMCR

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Pier Capital's IMCR Position: Q4 2024 in Review

Pier Capital sold out of Immunocore (IMCR) in Q4 2024, closing a stake of 82,480 shares — an estimated $2.57M sold.

Pier Capital first reported a position in IMCR in Q3 2021 and held it in 13 quarters. The position peaked at $8.14M in Q4 2021. 115 funds tracked by Wall St. Rank hold IMCR as of Q4 2024.

  • Pier Capital reported no remaining Immunocore position as of Q4 2024 after selling out during the quarter.
  • Pier Capital sold 82,480 Immunocore shares in Q4 2024, an estimated $2.57M.
  • Pier Capital first reported a position in Immunocore in Q3 2021 and held it in 13 quarters.
  • Pier Capital's Immunocore position peaked at $8.14M in Q4 2021.
  • 115 funds tracked by Wall St. Rank held Immunocore as of Q4 2024.

Based on Pier Capital's 13F filing for Q4 2024, filed 11 Feb 2025.